skip to Main Content

January 12, 2022
Integration of Viral Hepatitis Prevention and Treatment for People Who Inject Drugs
On February 3, 2022, TAG in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), will host this free webinar.

January 11, 2022
Grant Officer
TAG is seeking a dynamic, highly motivated, and organized Grant Officer to support grant and fundraising efforts. This position will report to TAG’s Director of Development, and is a full-time, salaried role. Apply today!

December 16, 2021
2021 TAG Update
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.

November 4, 2021
Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Technologies
Webinar / Presentation
On November 4, 2021, Treatment Action Group and the International Treatment Preparedness Coalition presented this webinar outlining the main findings of the upcoming report “Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis on Patenting Trends.”

November 4, 2021
Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
This new report offers recommendations to ensure access to long-acting technologies throughout the research and development process.

October 7, 2021
TAGline October 2021
Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they’re even used for birth control.

September 20, 2021
A Partnership to Expand Access to Lifesaving Testing and Treatment for Hepatitis C
Hepatitis C PACT was launched in 2021 and aims to tackle ongoing disparities in access to diagnostics and treatment for hepatitis C virus (HCV) in low-and middle-income countries (LMICs), home to 75% of people living with the viral illness. This brief explains the group’s goals and  work.

September 11, 2021
Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?
Webinar / Presentation
On September 11 2021, Treatment Action Group’s Joelle Dountio Ofinboudem presented new data on the registration of the hepatitis C cure at the Conference on Liver Disease in Africa (COLDA) 2021. The presentation titled, “Have a Heart, Save My Liver! Who Has Access to the Cure in Africa,” explains that accelerating…

August 27, 2021
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing
Statement / Press
TAG’s comprehensive analysis found that the public invested at least $252 million USD in the research and development of GeneXpert diagnostic technology, which stands in stark contrast to the lack of affordable pricing and favorable service and maintenance terms from the diagnostics company Cepheid.

July 28, 2021
Illustrated Glossary for Long-Acting Technologies
The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy. 

July 27, 2021
Launch of Public Health Partnership to Tackle the Silent Epidemic of Hepatitis C in Low- and Middle-Income Countries
Statement / Press
The Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND, the global alliance for diagnostics, and the Treatment Action Group are joining forces to tackle a ‘silent’ public health injustice: the continuing disparities in access to diagnostics and treatment for the hepatitis C virus (HCV) in low- and…

July 16, 2021
2021 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

June 7, 2021
Letter Demanding Unitaid Hepatitis Advocacy
Letter / Comment
Letter from TAG and other CSOs and NGOs to the Unitaid Executive Board demanding that Unitaid continue to invest in curing hepatitis C, and treating hepatitis B, as well as harm reduction.

June 4, 2021
2020 Annual Report
As the HIV epidemic changes over time, and new pandemics continue to emerge, TAG continues to evolve while remaining true to our activist roots. We partner with the most affected communities in the U.S. and around the world.

June 3, 2021
TAG Urges Governor to Sign New York State Bill Expanding Adult Vaccines Available in Pharmacies
Statement / Press
The bill, S4807A (Stavisky) / A6476A (Hyndman), improves preventive viral hepatitis vaccine access, and is particularly important for people who use drugs and unhoused New Yorkers.

Back To Top